7 January 2022: Viona issues Voluntary Nationwide Recall of Metformin HCl Extended-Release Tablets, USP 750 mg
11 June 2021: Viona issues Voluntary Nationwide Recall of Metformin HCl Extended-Release Tablets, USP 750 mg
We’re setting a new standard for high-quality, low-cost generics.
Viona Pharmaceuticals is an emerging generic pharmaceutical company established in May 2018 and located in Cranford, NJ. Viona is a wholly owned indirect subsidiary of Cadila Healthcare Limited, a fully integrated, global healthcare provider.
Learn More About UsClindamycin Phosphate Topical Solution, USP 1%
COMPARED TO: Cleocin T
THERAPEUTIC RATING: AT
THERAPEUTIC CATEGORY: Antibacterials
Felbamate Tablets, USP
COMPARED TO: Felbatol®
THERAPEUTIC RATING: AB
THERAPEUTIC CATEGORY: Antiseizure/Anticonvulsant
Desoximetasone Cream, USP 0.25%
COMPARED TO: Topicort®
THERAPEUTIC RATING: AB
THERAPEUTIC CATEGORY: Corticosteroids
PRODUCTS
Viona is currently marketing a range of Oral Solids and Topical products. We have a vast number of generic pharmaceutical products in the pipeline, which we are excited to introduce to the market soon.
Explore our Products
7 January 2022: Viona issues Voluntary Nationwide Recall of Metformin HCl Extended-Release Tablets, USP 750 mg
11 June 2021: Viona issues Voluntary Nationwide Recall of Metformin HCl Extended-Release Tablets, USP 750 mg